New poll: 76% of voters concerned Speaker Pelosi’s plan would result in fewer new medicines

The House of Representatives has spent much of this fall focused on Speaker Pelosi’s drug pricing bill, H.R.3, but a recent survey of nearly 2,000 registered voters confirms that H.R.3 is not the...
Read More
IP Explained: By the Numbers: How reliable IP protections promote a strong U.S. economy

The U.S. biopharmaceutical industry depends on predictable and reliable intellectual property (IP) protections, including patents, to maintain its role as the global leader in biopharmaceutical...
Read More
What they are saying: Negative impact of Pelosi’s plan on biopharmaceutical innovation

Recently, House Speaker Nancy Pelosi unveiled a radical drug pricing plan, H.R. 3, that would be the wrong approach for patients, the U.S. health care system and the economy.
Read More
Pelosi’s radical plan leaves lung cancer patients behind

Lung cancer is the second most common form of cancer in men and women and the leading cause of cancer-related deaths in the United States. In 2019 alone, there will be an estimated 228,000 new...
Read More
Pelosi’s radical plan would leave Alzheimer’s patients behind

Last month, House Speaker Nancy Pelosi unveiled a radical drug pricing plan, H.R. 3, that could jeopardize the development of innovative treatments for some of the most challenging diseases and...
Read More
Event tomorrow: Maintaining America’s leadership in access and innovation

Each year, biopharmaceutical companies invest nearly $100 billion in the discovery of new treatments and cures. Despite a challenging research and development (R&D) process, consistently high...
Read More
What they are saying: Broad opposition to Pelosi’s radical drug pricing plan

Recently, House Speaker Nancy Pelosi unveiled a radical drug pricing plan that would be the wrong approach for patients, the U.S. health care system, economy, and American innovation. An...
Read More
On Manufacturing Day, a closer look at the biopharmaceutical sector’s contributions

Each year, the first Friday in October marks Manufacturing Day, an annual recognition of the critical role manufacturing-intensive industries play in powering innovation and generating jobs and...
Read More
By the Numbers: Pelosi’s radical plan puts America’s economy and jobs at risk

We already know that the radical drug pricing plan unveiled last week by House Speaker Nancy Pelosi is the wrong approach for patients, the U.S. health care system, and American innovation. But...
Read More
World Trade Month: How we can expand world-class pro-innovation standards

May is World Trade Month—a celebration of the industries that import and export goods and services around the world. The month offers a good opportunity to examine the significance of...
Read More